debate right now over whether low-dose versions of Mevacor and Pravachol should be sold OTC

There's lots of debate right now over whether low-dose versions of Mevacor and Pravachol should be sold OTC. ...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote